Tension recordings in BAMG-regenerated and host bladder strips 4 months after surgery

	Strip Weight (mg.)	Tetrodotoxina (gm.)	Atropine Sulfateb (gm.)	Valethamate Bromideb (gm.)	Isoproterenolc (gm.)	Norepinephrinec (gm.)	Nitroprussided (gm.)
BAMG-	29.5 ± 4.0†	1.86 ± 0.3	1.94 ± 0.58		0.76 ± 0.04		0.98 ± 0.351
Regenerates		1.13 ± 0.48	0.0 ± 0.04*	0.0 ± 0.03*	0.0 ± 0.01*	0.0 ± 0.02*	0.65 ± 0.1
	(N = 19)	(N = 3)	(N = 3)	(N = 3)	(N = 2)	(N = 2)	(N = 4)
Host	37.2 ± 2.5	2.26 ± 0.43	2.42 ± 0.66		0.73 ± 0.04		2.03 ± 0.35
Bladder		0.81 ± 0.5*	0.0 ± 0.03*	0.0 ± 0.03*	0 ± 0.04*	0 ± 0.03*	1.69 ± 0.3
	(N = 30)	(N = 3)	(N = 5)	(N = 5)	(N = 2)	(N = 2)	(N = 8)

^aWith supramaximal elecrical field stimulation before (upper line) and after administration of tetrodotoxin 0.4 × 10⁻⁶ M (lower line).

^b15 min. after carbachol stimulation 10⁻⁴ M (upper line) and after subsequent administration of atropine sulfate 10⁻⁶ M and valethamate bormide 2.6 × 10⁻⁵ M (lower line).

^cBefore (upper line) and after (lower line) administration of isoproterenol 10⁻⁴ M and norepinephrine 5.6 × 10⁻⁴ M.

^d15 min. after potassium stimulation alone (upper line) and after subsequent administration of nitroprusside 10⁻⁴ M (lower line).

^*p<0.05 when compared with tension before administration of the drug.

^†p<0.05 when compared with host bladder strips.